See other companies on Otta

BrightInsight

IoT platform for medical device and biopharma companies

201-500 employees
  • Healthcare
  • B2B
  • Internet of Things
  • SaaS
6201 America Center Drive, San Jose, CA 95002

Company mission

To accelerate regulated digital health innovation for our biopharma and medtech customers through our scalable medical-grade platform.

Top investors

6% employee growth in 12 months

Otta's take

Theo Margolius headshot

Theo Margolius

COO of Otta

Using software for medical purposes is a twofold challenge, companies must ensure that they are complying with both security requirements and healthcare regulations. Medical software development often spans several teams within businesses as well as possibly external specialists and consultants.

BrightInsight aids clients by providing guidance for the development of new software. It responds to legislative changes and keeps customers updated, freeing up resources, letting clients focus on patient care, and improving their drug development time to market.

BrightInsight has already worked with big names, such as AstraZeneca and CSL Behring. The company created a dosing calculator to help with the treatment of hemophilia, BrightInsight was able to design, develop, and bring the software to market in about six months, considerably less than the industry standard.

Benefits

  • Life Insurance
  • Work from home opportunities
  • Matching 401K
  • Full range of medical benefits, dental, vision, etc
  • Paid Time Off

Company values

  • Passionate about transforming care and patient outcomes
  • Accountable to one another, our valued customers and our mission-critical projects
  • Respectful of one another, our customers and the data that we manage
  • Trust each other and display integrity in everything we do
  • Nimble and agile in our work, but without short cuts
  • Excellence in the products we deliver and people we hire
  • Real world impact – we aim to positively impact healthcare globally by executing every day on our mission of accelerating digital health innovation for our biopharma and medtech customers

Funding (last 2 of 3 rounds)

Mar 2021

$101m

SERIES C

Jun 2020

$40m

SERIES B

$166m

Total funding

This company has top investors

Founders

Kal Patel

(Co-founder & CEO)

Kal worked at BCG for over 5 years before working at NOVARTIS and founding Amgen. He served as President of Flex Digital and Senior Digital Health Advisor at BCG before co-founding BrightInsight in January 2019.

Ferry Tamtoro

(Co-founder)

Previously Ferry was a Technical Project Manager at GE Healthcare, a Product Manager at Walgreens and a Director for Digital Health Products at Amgen.